EE200100052A - Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi - Google Patents

Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi

Info

Publication number
EE200100052A
EE200100052A EEP200100052A EEP200100052A EE200100052A EE 200100052 A EE200100052 A EE 200100052A EE P200100052 A EEP200100052 A EE P200100052A EE P200100052 A EEP200100052 A EE P200100052A EE 200100052 A EE200100052 A EE 200100052A
Authority
EE
Estonia
Prior art keywords
carotenoid
antioxidant
composition containing
containing carnitine
antiproliferative composition
Prior art date
Application number
EEP200100052A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200100052A publication Critical patent/EE200100052A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200100052A 1998-08-03 1999-07-29 Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi EE200100052A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (it) 1998-08-03 1998-08-03 Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
PCT/IT1999/000251 WO2000007581A2 (en) 1998-08-03 1999-07-29 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid

Publications (1)

Publication Number Publication Date
EE200100052A true EE200100052A (et) 2002-06-17

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100052A EE200100052A (et) 1998-08-03 1999-07-29 Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi

Country Status (21)

Country Link
EP (1) EP1102584A2 (et)
JP (1) JP2002522382A (et)
KR (1) KR20010072146A (et)
CN (1) CN1311674A (et)
AR (1) AR021172A1 (et)
AU (1) AU5064199A (et)
BR (1) BR9912703A (et)
CA (1) CA2338035A1 (et)
EE (1) EE200100052A (et)
HK (1) HK1039062A1 (et)
HU (1) HUP0102807A2 (et)
IL (1) IL140797A0 (et)
IS (1) IS5816A (et)
IT (1) IT1302125B1 (et)
MA (1) MA26666A1 (et)
NO (1) NO20010532L (et)
PL (1) PL346161A1 (et)
SK (1) SK1252001A3 (et)
TN (1) TNSN99152A1 (et)
TR (1) TR200100333T2 (et)
WO (1) WO2000007581A2 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2518926T3 (es) 2000-06-02 2014-11-05 Board Of Regents, The University Of Texas System Conjugados de etilendicisteína y un análogo de glucosa
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (ko) 2001-10-29 2005-10-25 한국과학기술연구원 손바닥선인장 추출물 및 이로부터 분리된 화합물을함유하는 신경세포 보호용 조성물
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
JP4334189B2 (ja) * 2002-07-30 2009-09-30 カゴメ株式会社 Age生成阻害剤
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
WO2004092153A1 (ja) 2003-04-14 2004-10-28 Nippon Soda Co. Ltd. ジアミン誘導体、製造法及び抗酸化薬
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
JP2007519678A (ja) * 2004-01-28 2007-07-19 ネステク ソシエテ アノニム 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (ru) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Препарат для профилактики и лечения свободнорадикальной патологии у животных
CN113491687A (zh) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 一种解毒药物组合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ. コスバブ,ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito

Also Published As

Publication number Publication date
HK1039062A1 (zh) 2002-04-12
CA2338035A1 (en) 2000-02-17
WO2000007581A2 (en) 2000-02-17
TR200100333T2 (tr) 2001-07-23
IS5816A (is) 2001-01-16
KR20010072146A (ko) 2001-07-31
CN1311674A (zh) 2001-09-05
ITRM980516A1 (it) 2000-02-03
WO2000007581A3 (en) 2000-05-11
EP1102584A2 (en) 2001-05-30
MA26666A1 (fr) 2004-12-20
AU5064199A (en) 2000-02-28
IT1302125B1 (it) 2000-07-31
NO20010532D0 (no) 2001-01-31
ITRM980516A0 (it) 1998-08-03
TNSN99152A1 (fr) 2005-11-10
PL346161A1 (en) 2002-01-28
JP2002522382A (ja) 2002-07-23
IL140797A0 (en) 2002-02-10
NO20010532L (no) 2001-03-20
HUP0102807A2 (hu) 2002-03-28
SK1252001A3 (en) 2001-08-06
BR9912703A (pt) 2001-05-02
AR021172A1 (es) 2002-07-03

Similar Documents

Publication Publication Date Title
DE59901708D1 (de) Endoskop, insbesondere video-endoskop
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
IT1308659B1 (it) Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
DE69934884D1 (de) Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, und polyorthoester-polyethylene glycol-polyorthoester blockcopolymere
DK1112005T3 (da) Antioxiderende præparat, som omfatter acetyl-L-carnitin og alfa-lipoinsyre
NL1009331A1 (nl) Genonyleerde difenylaminen.
DE69736354D1 (de) Anthrapyridonverbindungen, wässrige tintenzusammensetzung und die damit gefärbten gegenstände
DE69708120D1 (de) Laser-absorbierende, lichtbleichbare zusammensetzungen
DE69521082D1 (de) Metallisches bakterizides Mittel
ZA9710593B (en) Antisebum and antioxidant compositions containing gugulipid and fractions thereof.
EE200100052A (et) Oksüdeerumisvastane, vohamisvastane kompositsioon, mis sisaldab karnitiini ning karotenoidi
DE69900817D1 (de) Verbindungsstreifen, verbindungsverfahren und einheit, die diesen verbindungs-streifen beinhaltet
MXPA03004366A (es) Composicion cosmetica suave con retinoides estabilizados.
GB9817235D0 (en) Compound,composition and use
NO20010873L (no) Mikropartikkel-blanding
IT1308660B1 (it) Reticolante per fotoresist e composizione fotoresist comprendente lostesso.
GB9817236D0 (en) Compound,composition and use
GB9903447D0 (en) Compound, composition and use
BR9903981B1 (pt) compostos e composiÇÕes de fragrancia de metilciclotetradec-5-en-1-onas.
TR199700147A2 (tr) Mikrop öldürücü terkip.
AU5341699A (en) Antiproliferative naphthoquinones, derivatives, compositions, and uses thereof
GB9817238D0 (en) Compound,composition and use
BR9503900A (pt) Composição polimérica útil como um antioxidante
ZA995878B (en) High voltage transformer.
DE69908213D1 (de) Verkorkungsmaschine